Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
MYOMO, INC.
| Metric | MYOMO, INC. MYOHealthcare |
|---|---|
| Quality Score | 63 / 100 |
| Revenue (latest) | $41M |
| Net income (latest) | −$16M |
| Operating margin | −35.2% |
| Net margin | −38.1% |
| Return on equity | −136.6% |
| Return on assets | −40.3% |
| Return on capital (ROCE) | −47.5% |
| Debt / equity | 2.39× |
| Revenue growth (YoY) | 25.7% |
| Altman Z″ (distress) | -8.82 |
| Accruals / assets | −2.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.